Hepatic Toxicity in Patients with Rheumatoid Arthritis and Psoriasis Taking Methotrexate Therapy

Authors

  • Haider Hamza Omran1, Basim Mohammed Mothlum1

DOI:

https://doi.org/10.37506/ijfmt.v14i2.2842

Keywords:

Hepatic Toxicity, MTX therapy, Arthritis

Abstract

Background: We had made a study to demonstrate the adverse hepatic effects of MTX in patients taking MTX for treatment of RA and psoriasis taking in consideration the following variables: BMI, gender, cumulative dose, age, weekly dose, duration of treatment, serum level of cholesterol and creatinine. Patient and method: We had a prospective study of 85 patients with RA and 50 patients with psoriasis. All patients were analyzed by history, clinical examination and investigations in the form of liver enzymes, blood sugar, serum cholesterol, serum creatinine, HBS Ag and anti HCV antibody. Persistently elevated level of liver enzymes 2 to 3 times the upper limit of normal on two occasions 3 months apart indicate hepatic toxicity Results: We found that 7 patients with psoriasis and 6 patients with RA have significant elevated liver enzymes which reflect MTX hepatotoxicity Conclusion: Our study show that patients with psoriasis at significantly greater risk of elevated liver enzymes than patient with RA (14% and 7% respectively) were gender, BMI, cumulative dose, weekly dose and serum cholesterol level are risk factors for hepatic toxicity due to MTX therap

Author Biography

Haider Hamza Omran1, Basim Mohammed Mothlum1

1Assist Prof./FICM. Internal medicine Merjan Teaching Hospital-Ministry of Health/Iraq

Published

2020-04-29

How to Cite

Haider Hamza Omran1, Basim Mohammed Mothlum1. (2020). Hepatic Toxicity in Patients with Rheumatoid Arthritis and Psoriasis Taking Methotrexate Therapy. Indian Journal of Forensic Medicine & Toxicology, 14(2), 463-468. https://doi.org/10.37506/ijfmt.v14i2.2842